These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 32301068)

  • 1. A diagnostic strategy for Lewy body disease using DAT-SPECT, MIBG and Combined index.
    Sakamoto F; Shiraishi S; Ogasawara K; Tsuda N; Nakagawa M; Tomiguchi S; Yamashita Y
    Ann Nucl Med; 2020 Jun; 34(6):415-423. PubMed ID: 32301068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer's disease.
    Shimizu S; Hirao K; Kanetaka H; Namioka N; Hatanaka H; Hirose D; Fukasawa R; Umahara T; Sakurai H; Hanyu H
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):184-192. PubMed ID: 26233438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined use of dopamine transporter imaging (DAT-SPECT) and
    Yoshii F; Ryo M; Baba Y; Koide T; Hashimoto J
    J Neurol Sci; 2017 Apr; 375():80-85. PubMed ID: 28320195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The usefulness of combined brain perfusion single-photon emission computed tomography, Dopamine-transporter single-photon emission computed tomography, and
    Kobayashi S; Makino K; Hatakeyama S; Ishii T; Tateno M; Iwamoto T; Tsujino H; Kawasaki K; Mikuni K; Ukai W; Murayama T; Hashimoto E; Utsumi K; Kawanishi C
    Psychogeriatrics; 2017 Jul; 17(4):247-255. PubMed ID: 28130808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of the combination of a SPECT study with [123I]-FP-CIT of dopamine transporters and [123I]-MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes.
    Uyama N; Otsuka H; Shinya T; Otomi Y; Harada M; Sako W; Izumi Y; Kaji R; Watanabe Y; Takashi S; Kunikane Y
    Nucl Med Commun; 2017 Jun; 38(6):487-492. PubMed ID: 28410288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Sensitivity and Symptomatic Relevance of Dopamine Transporter Imaging and Myocardial Sympathetic Scintigraphy in Patients with Dementia with Lewy Bodies.
    Tang Z; Hirano S; Koizumi Y; Izumi M; Kitayama Y; Yamagishi K; Tamura M; Ishikawa A; Kashiwado K; Iimori T; Mukai H; Yokota H; Horikoshi T; Uno T; Kuwabara S
    J Alzheimers Dis; 2024; 100(1):127-137. PubMed ID: 38848178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and (123) I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative study.
    Tiraboschi P; Corso A; Guerra UP; Nobili F; Piccardo A; Calcagni ML; Volterrani D; Cecchin D; Tettamanti M; Antelmi L; Vidale S; Sacco L; Merello M; Stefanini S; Micheli A; Vai P; Capitanio S; Gabanelli SV; Riva R; Pinto P; Biffi AM; Muscio C;
    Ann Neurol; 2016 Sep; 80(3):368-78. PubMed ID: 27398636
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Yoshii F; Moriya Y; Ohnuki T; Ryo M; Takahashi W; Kohara S; Hashimoto J
    Clin Neurol Neurosurg; 2017 Sep; 160():73-77. PubMed ID: 28689103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A diagnostic strategy for Parkinsonian syndromes using quantitative indices of DAT SPECT and MIBG scintigraphy: an investigation using the classification and regression tree analysis.
    Iwabuchi Y; Kameyama M; Matsusaka Y; Narimatsu H; Hashimoto M; Seki M; Ito D; Tabuchi H; Yamada Y; Jinzaki M
    Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1833-1841. PubMed ID: 33392714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of dementia with Lewy bodies: diagnostic performance of combined ¹²³I-IMP brain perfusion SPECT and ¹²³I-MIBG myocardial scintigraphy.
    Sakamoto F; Shiraishi S; Yoshida M; Tomiguchi S; Hirai T; Namimoto T; Hashimoto M; Ikeda M; Uetani H; Yamashita Y
    Ann Nucl Med; 2014 Apr; 28(3):203-11. PubMed ID: 24363079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [[(123)I]-Ioflupane SPECT in combination with MIBG myocardial scintigraphy in Parkinson's disease: a case series study].
    Yamada A; Murakami T; Kang Y; Iikuni Y; Morimatsu A; Shirata A; Ito H; Ugawa Y; Yamane K
    Rinsho Shinkeigaku; 2016 Jun; 56(6):400-6. PubMed ID: 27212677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early diagnosis of Lewy body disease in patients with late-onset psychiatric disorders using clinical history of rapid eye movement sleep behavior disorder and [
    Fujishiro H; Okuda M; Iwamoto K; Miyata S; Torii Y; Iritani S; Ozaki N
    Psychiatry Clin Neurosci; 2018 Jun; 72(6):423-434. PubMed ID: 29536584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iodine-123 metaiodobenzylguanidine scintigraphy and iodine-123 ioflupane single photon emission computed tomography in Lewy body diseases: complementary or alternative techniques?
    Treglia G; Cason E; Cortelli P; Gabellini A; Liguori R; Bagnato A; Giordano A; Fagioli G
    J Neuroimaging; 2014; 24(2):149-54. PubMed ID: 23163913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential diagnostic value of regional myocardial adrenergic imaging using (123)I-MIBG SPECT to identify patients with Lewy body diseases.
    Lebasnier A; Lamotte G; Manrique A; Peyronnet D; Bouvard G; Defer G; Agostini D
    Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1043-51. PubMed ID: 25626701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [(123)I-MIBG myocardial scintigraphy in the diagnosis of Lewy body dementia].
    Marquié Sayagués M; Da Silva Alves L; Molina-Porcel L; Alcolea Rodríguez D; Sala Matavera I; Sánchez-Saudinós MB; Camacho Martí V; Estorch Cabrera M; Blesa González R; Blesa González R; Gómez-Isla T; Gómez-Isla T; Lleó Bisa A; Lleó Bisa A
    Neurologia; 2010 Sep; 25(7):414-21. PubMed ID: 20964987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy of DAT-SPECT and MIBG scintigraphy for dementia with Lewy bodies: an updated systematic review and Bayesian latent class model meta-analysis.
    Nihashi T; Ito K; Terasawa T
    Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1984-1997. PubMed ID: 31423561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroimaging for diagnosing dementia with Lewy bodies: What is the best neuroimaging technique in discriminating dementia with Lewy bodies from Alzheimer's disease?
    Shimizu S; Kanetaka H; Hirao K; Fukasawa R; Namioka N; Hatanaka H; Hirose D; Umahara T; Sakurai H; Hanyu H
    Geriatr Gerontol Int; 2017 May; 17(5):819-824. PubMed ID: 27138074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy and cutoff values of delayed heart to mediastinum ratio with (123)I-metaiodobenzylguanidine cardiac scintigraphy for Lewy body disease diagnoses.
    Lamotte G; Morello R; Lebasnier A; Agostini D; Defer GL
    BMC Neurol; 2015 May; 15():83. PubMed ID: 25971430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Dopamine Transporter SPECT and 123I-MIBG Myocardial Scintigraphy to Assess Clinical Severity in Patients With Parkinson Disease.
    Okano N; Niitsu M; Tanaka J; Sasaki T; Takahashi K; Araki N; Yamamoto T; Nakano S; Nishimura S; Senbonmatsu T; Matsunari I
    Clin Nucl Med; 2017 Jan; 42(1):7-14. PubMed ID: 27775946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive Olfactory Impairment and Cardiac Sympathetic Denervation in REM Sleep Behavior Disorder.
    Janzen A; Vadasz D; Booij J; Luster M; Librizzi D; Henrich MT; Timmermann L; Habibi M; Sittig E; Mayer G; Geibl F; Oertel W
    J Parkinsons Dis; 2022; 12(6):1921-1935. PubMed ID: 35754288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.